Depression: Social Stress, Inflammation, Neuromodulatory, and Neural Network Perspectives

  • 3,609

    Total downloads

  • 19k

    Total views and downloads

About this Research Topic

Submission closed

Background

Depression is now the leading health condition in Western societies, and also the leading cause of disability. Its causes remain opaque, and although we have had a strong gravitation to both molecular reductionism and serial primary factor concepts in biological psychiatry, many nominated ‘primary factors’ are in fact deeply interactive with each other rather than any version of isolated ‘prime movers’.

Additionally, depression may have a privileged and special relationship with several classes of common organismic stressors, particularly social loss/defeat, physical pain, and inflammation, especially from innate immunity. Biological drivers within the depressive process however have been indexed to virtually every neural signaling and regulatory system influencing the brain: three classic amine systems, the cholinergic system, multiple social neuropeptide systems, small molecule GABA and glutamate systems, the immune system, the HPA stress axis and perhaps beyond that, several endocrine systems. These various factors create complex interactive loops in their relationships with each other, and where trailing and leading edges are often elusive, suggesting a highly distributed causality into a final shared trajectory. Depression also has sibling relationships (indexed by heavy mechanistic overlap) with other conserved behavioral shutdown mechanisms, particularly sickness behavior, but also hibernation, suggesting mammalian conservation.

The crisis of depression has been amplified by the protraction of the Covid 19 pandemic, which has underscored (among other things) the intimate relationship between sickness behavior and risk for depression, and how social isolation and the pre-existing epidemic of loneliness in Western societies have been further exacerbated in Covid 19. Emerging pro-inflammatory perspectives on depression that emphasize its intrinsic kinship with sickness behavior have been complemented by an increasing focus on moderating pro-inflammatory lifestyles, as both preventing and potentially treating or at least mitigating depression, most especially exercise but also improved sleep and reduction of pro-inflammatory diet patterns.

The goal would be to assemble pieces of disparate literatures, often not assembled in the same place, that might together constitute much of the full fabric of a ‘big picture’ of depression, including summaries of recent paradigm shifting treatment options (psychedelic therapies, ketamine and also EBS results).

One can see from this list of topics in the background statement that we are deliberately trying to cast a wide net. Part of the problem with depression has been a monocular focus and a serial gravitation to single factor theories, and an unproductive search for a prime mover when the evidence argues increasingly that depression emerges from recursive interactions between many neurobiological systems. On the treatment side, there is also much evidence for multiple and disparate antidepressant interventions and putative mechanisms. This multifactorial nature of both the syndrome and its treatments have contrasted with the general assumption that reductive molecular approaches, often linked to a putative primary factor theory, will eventually yield better rational therapeutics, but this hope for the most part has not been realized.

Contributions might summarize research related to all of the relevant neurobiological systems, most particularly the immune system, and the stress axis, two systems traditionally modelled in isolation but where changes in these systems are conjoined in prototypical depressogenic social stressors of loss and defeat. Summaries of changes in relevant aminergic, peptidergic and small molecule GABA and glutamate systems in depression, would also be valuable. Given that depression is associated with large-scale corticolimbic network changes, summaries of work neural network perspectives would be valuable.

Summaries of outcome research in traditional pharmacology, in various modes and types of psychotherapy, and other nontraditional models of intervention (such as yoga, meditation, exercise, nutritional interventions, improved sleep hygiene etc. etc.) would also be a contribution. Additionally, summaries of relevant animal models, along with summaries of work on emerging biomarkers, two areas with many challenges, but therefore also much opportunity for scientific progress, would also be welcomed. Summaries of newer non-traditional pharma approaches with ketamine and psychedelics would be valuable. Summaries of EBS results would also be welcomed. Because of the large number of relevant topical areas, we are seeking overviews and literature summaries rather than primary empirical studies. Summaries of many relevant empirical studies that have already been vetted through standard peer review of course would be clearly part of the topical reviews.

Keywords: Stress axis, Inflammation, Sickness Behavior, Ketamine, Monoamines, Neuropeptides, Psychotherapy, Separation distress, Affective neuroscience

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.